91 related articles for article (PubMed ID: 26272149)
21. Quantitative metabolome analysis using liquid chromatography-high-resolution mass spectrometry.
Kiefer P; Portais JC; Vorholt JA
Anal Biochem; 2008 Nov; 382(2):94-100. PubMed ID: 18694716
[TBL] [Abstract][Full Text] [Related]
22. Dual labeling of metabolites for metabolome analysis (DLEMMA): A new approach for the identification and relative quantification of metabolites by means of dual isotope labeling and liquid chromatography-mass spectrometry.
Feldberg L; Venger I; Malitsky S; Rogachev I; Aharoni A
Anal Chem; 2009 Nov; 81(22):9257-66. PubMed ID: 19845344
[TBL] [Abstract][Full Text] [Related]
23. Measurement of homocysteine and related metabolites in human plasma and urine by liquid chromatography electrospray tandem mass spectrometry.
Rafii M; Elango R; House JD; Courtney-Martin G; Darling P; Fisher L; Pencharz PB
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(28):3282-91. PubMed ID: 19481985
[TBL] [Abstract][Full Text] [Related]
24. DnsID in MyCompoundID for rapid identification of dansylated amine- and phenol-containing metabolites in LC-MS-based metabolomics.
Huan T; Wu Y; Tang C; Lin G; Li L
Anal Chem; 2015 Oct; 87(19):9838-45. PubMed ID: 26327437
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometry-based microbial metabolomics.
Baidoo EE; Benke PI; Keasling JD
Methods Mol Biol; 2012; 881():215-78. PubMed ID: 22639216
[TBL] [Abstract][Full Text] [Related]
26. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
[TBL] [Abstract][Full Text] [Related]
27. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
28. Metabolome analysis for discovering biomarkers of gastroenterological cancer.
Suzuki M; Nishiumi S; Matsubara A; Azuma T; Yoshida M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():59-69. PubMed ID: 24636738
[TBL] [Abstract][Full Text] [Related]
29. Analytical Methods for Mass Spectrometry-Based Metabolomics Studies.
Wang S; Blair IA; Mesaros C
Adv Exp Med Biol; 2019; 1140():635-647. PubMed ID: 31347076
[TBL] [Abstract][Full Text] [Related]
30. Measurement of concentrations of whole blood levels of choline, betaine, and dimethylglycine and their relations to plasma levels.
Awwad HM; Kirsch SH; Geisel J; Obeid R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():41-5. PubMed ID: 24674988
[TBL] [Abstract][Full Text] [Related]
31. Assay of Bile Acid Conjugation and Excretion in Human Hepatocytes.
Johansson H; Ellis EC
Methods Mol Biol; 2015; 1250():323-31. PubMed ID: 26272155
[TBL] [Abstract][Full Text] [Related]
32. A rapid and sensitive assay to quantify valproyl 1-O-acyl glucuronide in supernatants of sandwich-cultured rat hepatocytes using ultra-high performance liquid chromatography-tandem mass spectrometry.
Surendradoss J; Szeitz A; Teng XW; Chang TK; Abbott FS
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():40-9. PubMed ID: 23827518
[TBL] [Abstract][Full Text] [Related]
33. [Metabolome and mass spectrometry: new biomedical analysis perspectives].
Chao De La Barca JM; Mirebeau-Prunier D; Moal V; Reynier P; Garnotel R; Simard G
Ann Biol Clin (Paris); 2015; 73(1):126-30. PubMed ID: 25582729
[TBL] [Abstract][Full Text] [Related]
34. Targeted metabolomics.
Roberts LD; Souza AL; Gerszten RE; Clish CB
Curr Protoc Mol Biol; 2012 Apr; Chapter 30():Unit 30.2.1-24. PubMed ID: 22470063
[TBL] [Abstract][Full Text] [Related]
35. Distinct metabolic differences between various human cancer and primary cells.
Dettmer K; Vogl FC; Ritter AP; Zhu W; Nürnberger N; Kreutz M; Oefner PJ; Gronwald W; Gottfried E
Electrophoresis; 2013 Oct; 34(19):2836-47. PubMed ID: 23857076
[TBL] [Abstract][Full Text] [Related]
36. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
[TBL] [Abstract][Full Text] [Related]
37. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
38. Quantitative metabolomic profiling using dansylation isotope labeling and liquid chromatography mass spectrometry.
Zhou R; Li L
Methods Mol Biol; 2014; 1198():127-36. PubMed ID: 25270927
[TBL] [Abstract][Full Text] [Related]
39. Analysis of skeletal muscle metabolome: evaluation of extraction methods for targeted metabolite quantification using liquid chromatography tandem mass spectrometry.
El Rammouz R; Létisse F; Durand S; Portais JC; Moussa ZW; Fernandez X
Anal Biochem; 2010 Mar; 398(2):169-77. PubMed ID: 20026296
[TBL] [Abstract][Full Text] [Related]
40. Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy.
Xia JF; Liang QL; Liang XP; Wang YM; Hu P; Li P; Luo GA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1930-6. PubMed ID: 19501555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
